Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–18 of 18 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT06462196
- Conditions
- Analgesics, Anesthetics, Anesthetics, Dissociative, +27 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT06511908
- Conditions
- Behavior, Behavioral Symptoms, Depression, +12 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT06535568
- Conditions
- Acute Coronary Syndrome, Antineoplastic Agents, Arterial Occlusive Diseases, +23 more
- Locations
-
- IRCCS Auxologico Milano Milan, MI, Italy
NCT04289142
- Conditions
- Analgesics, Analgesics, Non-Narcotic, Central Nervous System Depressants, +16 more
- Locations
-
- Royal Columbian Hospital Vancouver, British Columbia, Canada
- St. Paul's Hospital Vancouver, British Columbia, Canada
- London Health Sciences London, Ontario, Canada
- Sunnybrook Health Sciences Centre Toronto, Ontario, Canada
NCT04572451
- Conditions
- Antineoplastic Agents, Antineoplastic Agents, Immunological, Immune Checkpoint Inhibitors, +15 more
- Locations
-
- University of Chicago Medical Center Chicago, Illinois, United States
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
NCT05465031
- Conditions
- Angiotensin II Type 1 Receptor Blockers, Angiotensin Receptor Antagonists, Antihypertensive Agents, +24 more
- Locations
-
- Regional Cancer Centre in Opole Opole, Opole Voivodeship, Poland
- Maria Sklodowska-Curie Institute - Oncology Centre (MSCI), Gliwice Branch Gliwice, Silesian Voivodeship, Poland
- Silesian Center for Heart Diseases Zabrze, Silesian Voivodeship, Poland
- Holy Cross Cancer Centre, Cardio-Oncology Division Kielce, Świętokrzyskie Voivodeship, Poland
NCT03646292
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Disease, +19 more
- Locations
-
- Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea Seoul, South Korea
NCT05657860
- Conditions
- Aberrant Motor Behavior in Dementia, Abnormalities, Multiple, Aggression, +34 more
- Locations
-
- Maimonides Medical Center Brooklyn, New York, United States
NCT04518852
- Conditions
- Adenocarcinoma, Antineoplastic Agents, Carcinoma, +13 more
- Locations
-
- Sichuan Cancer Hospital and Research Institute Chengdu, Sichuan, China
NCT05321602
- Conditions
- Antipsychotic Agents, Central Nervous System Depression, Mental Disorders, +9 more
- Locations
-
- Woodland International Research Group Little Rock, Arkansas, United States
- CNS Research Garden Grove, California, United States
- NRC Research Institute Orange, California, United States
- Collaborative Neuroscience Network, LLC Torrance, California, United States
NCT04922593
- Conditions
- Antipsychotic Agents, Central Nervous System Depressants, Mental Disorders, +10 more
- Locations
-
- Collaborative Neuroscience Network, Inc. Garden Grove, California, United States
- Synergy San Diego Lemon Grove, California, United States
- CNS Network, LLC Torrance, California, United States
- Innovative Clinical Research, Inc. Miami Lakes, Florida, United States
NCT03572790
- Conditions
- Antidepressive Agents, Behavior, Behavioral Symptoms, +6 more
- Locations
-
- University of Oxford Oxford, United Kingdom
Completed
Using Non-invasive Brain Stimulation (tDCS) With Varenicline for Treating Tobacco Dependence
NCT03841292
- Conditions
- Behavior, Behavior, Addictive, Chemically-Induced Disorders, +14 more
- Locations
-
- Centre for Addiction and Mental Health Toronto, Ontario, Canada
NCT03403777
- Conditions
- Antineoplastic Agents, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- National Cancer Institute Bratislava, Slovakia
NCT03863366
- Conditions
- Antidepressive Agents, Behavior, Behavioral Symptoms, +7 more
- Locations
-
- University of Oxford Oxford, United Kingdom
NCT03107013
- Conditions
- Molecular Mechanisms of Pharmacological Action
- Locations
-
- Quotient Clinical Ruddington, United Kingdom
Active, Not Recruiting
A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)
NCT07210463
- Conditions
- Acetylcholine Release Inhibitors, Botulinum Toxins, Type A, Cholinergic Agents, +7 more
- Locations
-
- Merz Investigative Site Lyon, France
- Merz Investigative Site Munich, Bavaria, Germany
- Merz Investigative Site Blankenfelde-Mahlow, Brandenburg, Germany
- Merz Investigative Site Potsdam, Brandenburg, Germany
Active, Not Recruiting
A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States
NCT07122193
- Conditions
- Acetylcholine Release Inhibitors, Botulinum Toxins, Type A, Cholinergic Agents, +7 more
- Locations
-
- Merz Investigative Site Scottsdale, Arizona, United States
- Merz Investigative Site Encino, California, United States
- Merz Investigative Site Los Angeles, California, United States
- Merz Investigative Site Redondo Beach, California, United States